DE2347225C3 - Verwendung von Spurenelementen bei der Injektionstherapie - Google Patents
Verwendung von Spurenelementen bei der InjektionstherapieInfo
- Publication number
- DE2347225C3 DE2347225C3 DE2347225A DE2347225A DE2347225C3 DE 2347225 C3 DE2347225 C3 DE 2347225C3 DE 2347225 A DE2347225 A DE 2347225A DE 2347225 A DE2347225 A DE 2347225A DE 2347225 C3 DE2347225 C3 DE 2347225C3
- Authority
- DE
- Germany
- Prior art keywords
- copper
- animals
- injection
- zinc
- sheep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000011573 trace mineral Substances 0.000 title claims description 30
- 235000013619 trace mineral Nutrition 0.000 title claims description 30
- 238000002560 therapeutic procedure Methods 0.000 title claims description 3
- 238000002347 injection Methods 0.000 title description 65
- 239000007924 injection Substances 0.000 title description 65
- 241001465754 Metazoa Species 0.000 claims description 77
- 239000010949 copper Substances 0.000 claims description 73
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 66
- 229910052802 copper Inorganic materials 0.000 claims description 64
- 239000011701 zinc Substances 0.000 claims description 44
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 43
- 229910052725 zinc Inorganic materials 0.000 claims description 43
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 14
- 229910052751 metal Inorganic materials 0.000 claims description 14
- 239000002184 metal Substances 0.000 claims description 14
- 229910052748 manganese Inorganic materials 0.000 claims description 13
- 239000011572 manganese Substances 0.000 claims description 13
- 150000002739 metals Chemical class 0.000 claims description 6
- 238000010254 subcutaneous injection Methods 0.000 claims description 2
- 239000007929 subcutaneous injection Substances 0.000 claims description 2
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 241001494479 Pecora Species 0.000 description 43
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 22
- 230000004054 inflammatory process Effects 0.000 description 19
- 206010061218 Inflammation Diseases 0.000 description 18
- 241000283690 Bos taurus Species 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 16
- 102100023321 Ceruloplasmin Human genes 0.000 description 15
- 108010075016 Ceruloplasmin Proteins 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 239000004006 olive oil Substances 0.000 description 15
- 235000008390 olive oil Nutrition 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 238000010255 intramuscular injection Methods 0.000 description 12
- 239000007927 intramuscular injection Substances 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- 239000011787 zinc oxide Substances 0.000 description 11
- 239000005751 Copper oxide Substances 0.000 description 10
- 229910000431 copper oxide Inorganic materials 0.000 description 10
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 244000309466 calf Species 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 244000025254 Cannabis sativa Species 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000003307 slaughter Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000010941 cobalt Substances 0.000 description 4
- 229910017052 cobalt Inorganic materials 0.000 description 4
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 206010010957 Copper deficiency Diseases 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010024769 Local reaction Diseases 0.000 description 2
- 241000209082 Lolium Species 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- 206010048259 Zinc deficiency Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000036796 hyperbilirubinemia Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- TYTHZVVGVFAQHF-UHFFFAOYSA-N manganese(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Mn+3].[Mn+3] TYTHZVVGVFAQHF-UHFFFAOYSA-N 0.000 description 2
- GEYXPJBPASPPLI-UHFFFAOYSA-N manganese(III) oxide Inorganic materials O=[Mn]O[Mn]=O GEYXPJBPASPPLI-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 244000089409 Erythrina poeppigiana Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 240000004296 Lolium perenne Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000009776 Rathbunia alamosensis Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 231100000739 chronic poisoning Toxicity 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- FRVMKTLTJFPELD-UHFFFAOYSA-N copper trimer Chemical compound [Cu].[Cu].[Cu] FRVMKTLTJFPELD-UHFFFAOYSA-N 0.000 description 1
- VVYPIVJZLVJPGU-UHFFFAOYSA-L copper;2-aminoacetate Chemical compound [Cu+2].NCC([O-])=O.NCC([O-])=O VVYPIVJZLVJPGU-UHFFFAOYSA-L 0.000 description 1
- BQYFJIGJGFIVEW-UHFFFAOYSA-L copper;methanedisulfonate Chemical compound [Cu+2].[O-]S(=O)(=O)CS([O-])(=O)=O BQYFJIGJGFIVEW-UHFFFAOYSA-L 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- -1 ethanol Chemical compound 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000012256 powdered iron Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000007425 progressive decline Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 238000009489 vacuum treatment Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7233282A FR2199459B1 (OSRAM) | 1972-09-20 | 1972-09-20 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2347225A1 DE2347225A1 (de) | 1974-04-04 |
| DE2347225B2 DE2347225B2 (de) | 1980-12-18 |
| DE2347225C3 true DE2347225C3 (de) | 1981-08-13 |
Family
ID=9104511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2347225A Expired DE2347225C3 (de) | 1972-09-20 | 1973-09-19 | Verwendung von Spurenelementen bei der Injektionstherapie |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3923982A (OSRAM) |
| DE (1) | DE2347225C3 (OSRAM) |
| FR (1) | FR2199459B1 (OSRAM) |
| GB (1) | GB1429062A (OSRAM) |
| NL (1) | NL176526C (OSRAM) |
| ZA (1) | ZA737383B (OSRAM) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4156427A (en) * | 1976-01-23 | 1979-05-29 | The Curators Of The University Of Missouri | Injectable male animal sterilant for selectively controlling the function of testes |
| US4339438A (en) * | 1976-01-23 | 1982-07-13 | The Curators Of The University Of Missouri | Injectable male animal sterilant for selectively controlling the function of testes |
| US4273763A (en) * | 1978-01-23 | 1981-06-16 | Efamol Limited | Pharmaceutical and dietary compositions |
| US4349536A (en) * | 1980-03-11 | 1982-09-14 | Hausler Kenneth J | Method of promoting suntan using a cream containing zinc and copper salts |
| DE3530901A1 (de) * | 1985-08-29 | 1987-03-12 | Roller Joachim | Mineralhaltiges ergaenzungs-nahrungsmittel |
| US4677118A (en) * | 1985-10-01 | 1987-06-30 | Elena Avram | Composition and method for treatment of copper deficiency |
| CA1303498C (en) * | 1985-10-01 | 1992-06-16 | Emanuel Revici | Composition and method for treatment of copper deficiency |
| WO1995019178A1 (en) * | 1994-01-13 | 1995-07-20 | Research Foundation For Mental Hygiene, Inc. | Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders |
| US6669966B1 (en) | 2000-01-06 | 2003-12-30 | Marantech Holding Llc | Compositions for facilitating skin growth and methods and articles using same |
| AU784597B2 (en) * | 2000-01-06 | 2006-05-11 | Marantech Holding, Llc | Methods of using electron active compounds for managing cancer |
| US20040022868A1 (en) * | 2000-01-06 | 2004-02-05 | Marantech Holding Llc | Compositions using tetrasilver tetroxide and methods for management of skin conditions using same |
| US20060105057A1 (en) * | 2000-01-06 | 2006-05-18 | Marantech Holding, Llc | Compositions using tetrasilver tetroxide and methods for management of skin conditions using same |
| US6645531B1 (en) | 2000-01-06 | 2003-11-11 | Marantech Holding Llc | Multivalent electron active compositions and methods of making and using same |
| US6485755B1 (en) | 2000-01-06 | 2002-11-26 | Marantech Holding | Methods of using electron active compounds for managing cancer |
| EP3636270B1 (en) * | 2008-12-09 | 2021-10-27 | Warburton Technology Limited | Trace elements |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR348010A (fr) * | 1904-11-18 | 1905-03-29 | Pierre Hermann Klein | Procédé et appareil pour la neutralisation des huiles comestibles |
| US1567847A (en) * | 1920-10-04 | 1925-12-29 | Kato Jinshichi | Injection for hemorrhoids |
| DE489314C (de) * | 1923-03-14 | 1930-01-16 | Agoleum Ges M B H | Verfahren zur Herstellung von haltbaren, kolloidalen Loesungen des Silbers oder des Quecksilbers neben Silber in Pflanzen- und tierischen OElen, Fetten oder deren Fettsaeuren |
| FR984439A (fr) * | 1943-09-24 | 1951-07-05 | Procédé pour la préparation des colloïdes métalliques | |
| US2476351A (en) * | 1945-06-07 | 1949-07-19 | Parke Davis & Co | Injectable penicillin compositions |
| US2951014A (en) * | 1957-01-03 | 1960-08-30 | Upjohn Co | Process for a stable oil suspension |
| US3712291A (en) * | 1968-10-02 | 1973-01-23 | M Freeman | Method for administering iron and other metals |
-
1972
- 1972-09-20 FR FR7233282A patent/FR2199459B1/fr not_active Expired
-
1973
- 1973-09-18 ZA ZA737383*A patent/ZA737383B/xx unknown
- 1973-09-19 GB GB4397573A patent/GB1429062A/en not_active Expired
- 1973-09-19 DE DE2347225A patent/DE2347225C3/de not_active Expired
- 1973-09-19 US US398626A patent/US3923982A/en not_active Expired - Lifetime
- 1973-09-20 NL NLAANVRAGE7313002,A patent/NL176526C/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US3923982A (en) | 1975-12-02 |
| NL176526B (nl) | 1984-12-03 |
| GB1429062A (en) | 1976-03-24 |
| DE2347225A1 (de) | 1974-04-04 |
| FR2199459A1 (OSRAM) | 1974-04-12 |
| NL7313002A (OSRAM) | 1974-03-22 |
| DE2347225B2 (de) | 1980-12-18 |
| ZA737383B (en) | 1974-08-28 |
| AU6047873A (en) | 1975-03-20 |
| FR2199459B1 (OSRAM) | 1975-08-08 |
| NL176526C (nl) | 1985-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2347225C3 (de) | Verwendung von Spurenelementen bei der Injektionstherapie | |
| DE68905096T2 (de) | Niacin und guar-mehl enthaltende zusammensetzung. | |
| DE2712786C2 (OSRAM) | ||
| DE69733089T2 (de) | Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin | |
| DE69922787T2 (de) | N,n'-bis(2-hydroxybenzyl)ethylendiamin-n,n'-diessigsäure und natriumsalze davon zur eisenchelatierungstherapie | |
| EP2557941B1 (de) | Tierfutterzusatz mit antimikrobieller und leistungsfördernder wirkung | |
| DE2512391C2 (de) | Mittel zur Behandlung der Mastitis in Milchtieren | |
| EP0460622B1 (de) | Arzneimittelzubereitung zur systemischen Behandlung von Zier- und Nutzfischen | |
| DE2802273C3 (de) | Verfahren zur Herstellung von Suppositorien aus Aminoglycid-Antibiotica | |
| DE2323187A1 (de) | Verfahren zur herstellung einer stabilisierten, pulverfoermigen secretinzubereitung durch gefriertrocknung | |
| DE1808948A1 (de) | Schmerzlos injizierbares Arzneimittelgemisch | |
| DE2640322A1 (de) | Medizinische zubereitung mit einem gehalt an nebennierenrindenhormon und einem ein schilddruesenstimulierendes hormon freisetzenden hormon | |
| DE2720288C2 (de) | Verwendung von Magnesiumsalzen zur Herstellung von Zubereitungen zur Behandlung von Nutztieren | |
| DE2427732A1 (de) | Mittel zum anaesthesieren von saeugetieren | |
| CH677608A5 (OSRAM) | ||
| DE3505572C2 (OSRAM) | ||
| DE69233432T2 (de) | Verbesserte zusammensetzungen für die euthanasie | |
| DE69425345T2 (de) | Anwendung von Selegilin in Tiermedizin | |
| DE69118685T3 (de) | Zusammensetzungen für euthanasie | |
| DE3104282C2 (OSRAM) | ||
| Rembold et al. | Über den Weiselzellenfuttersaft der Honigbiene, V. Untersuchungen über die Bildung des Futtersaftes in der Ammenbiene. | |
| DE1692463B2 (de) | Wachstum und entwicklung von nutztieren und gefluegel foerderndes, cystein und homocystein enthaltendes mittel | |
| DE2806910A1 (de) | Mittel zur desensibilisierung von flohstichen | |
| DE1016106B (de) | Mittel zur Verbesserung der Wollausbeute, insbesondere von Schafen | |
| DE1792295C (de) | Pharmazeutisches Präparat enthaltend 1-Aminomethyladamantan. Ausscheidung aus: 1468769 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| 8339 | Ceased/non-payment of the annual fee |